The Valley Desk

Clinical trial reportJCO precision oncologyPublished

Sunitinib in Patients With Various Solid Tumors With FGFR1/2 Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
JCO precision oncology
Published
Subject terms
Humans; Neoplasms; Antineoplastic Agents; Registries; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Fibroblast Growth Factor, Type 2
PubMed ID
42842844
Added to directory
Source checked

Report a correction or request removal